JPMorgan Chase & Co’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $40.5K | Buy |
|
|||||
|
2025
Q2 | $23.3K | Sell |
|
|||||
|
2025
Q1 | $40.6K | Buy |
|
|||||
|
2024
Q4 | $64.7K | Sell |
|
|||||
|
2024
Q3 | $141K | Sell |
|
|||||
|
2024
Q2 | $152K | Buy |
|
|||||
|
2024
Q1 | $216K | Sell |
|
|||||
|
2023
Q4 | $4.66M | Buy |
|
|||||
|
2023
Q3 | $3.07M | Sell |
|
|||||
|
2023
Q2 | $6.71M | Sell |
|
|||||
|
2023
Q1 | $8.03M | Buy |
|
|||||
|
2022
Q4 | $6.26M | Buy |
|
|||||
|
2022
Q3 | $7.74M | Buy |
|
|||||
|
2022
Q2 | $2.11M | Buy |
|
|||||
|
2022
Q1 | $2.36M | Sell |
|
|||||
|
2021
Q4 | $4.52M | Sell |
|
|||||
|
2021
Q3 | $5.57M | Sell |
|
|||||
|
2021
Q2 | $6.03M | Buy |
|
|||||
|
2021
Q1 | $2.31M | Sell |
|
|||||
|
2020
Q4 | $1.53M | Buy |
|
|||||
|
2020
Q3 | $90K | Buy |
|
|||||
|
2020
Q2 | $41K | Buy |
|
|||||
|
2020
Q1 | $39K | Sell |
|
|||||
|
2019
Q4 | $87K | Buy |
|
|||||
|
2019
Q3 | $58K | Buy |
|
|||||
|
2019
Q2 | $114K | Buy |
|
|||||
|
2019
Q1 | $88K | Buy |
|
|||||
|
2018
Q4 | $104K | Buy |
|
|||||
|
2018
Q3 | $151K | Sell |
|
|||||
|
2018
Q2 | $684K | Sell |
|
|||||
|
2018
Q1 | $859K | Sell |
|
|||||
|
2017
Q4 | $1.07M | Buy |
|
|||||
|
2017
Q3 | $1.29M | Sell |
|
|||||
|
2017
Q2 | $1.78M | Sell |
|
|||||
|
2017
Q1 | $3.98M | Sell |
|
|||||
|
2016
Q4 | $4.21M | Buy |
|
|||||
|
2016
Q3 | $5.26M | Buy |
|
|||||
|
2016
Q2 | $1.79M | Sell |
|
|||||
|
2016
Q1 | $1.56M | Sell |
|
|||||
|
2015
Q4 | $1.79M | Sell |
|
|||||
|
2015
Q3 | $1.48M | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $225K | Sell |
|
|||||
|
2013
Q2 | $1.54M | Buy |
|